Valuation: BioGaia AB

Market Cap 12.04B 1.24B 1.09B 1.01B 926M 1.75B 120B 1.78B 4.72B 58.63B 4.67B 4.56B 202B P/E 2026 *
30x
P/E 2027 * 24.5x
Enterprise Value 11.36B 1.17B 1.03B 950M 874M 1.65B 113B 1.68B 4.45B 55.35B 4.4B 4.31B 191B EV / Sales 2026 *
6.82x
EV / Sales 2027 * 6.1x
Free-Float
80.82%
Yield 2026 *
3.53%
Yield 2027 * 3.78%
1 day-0.76%
1 week+1.36%
Current month+1.97%
1 month+2.94%
3 months-1.89%
6 months+10.37%
Current year+12.24%
1 week 113.8
Extreme 113.8
128.4
1 month 113.8
Extreme 113.8
128.4
Current year 97.5
Extreme 97.5
136.3
1 year 93.2
Extreme 93.2
136.3
3 years 91.45
Extreme 91.45
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 45.8
Extreme 45.8
139.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2023
Director of Finance/CFO 59 05/11/2019
Chief Operating Officer 49 01/01/2021
Director TitleAgeSince
Chairman 77 01/01/2003
Chairman 76 25/04/2018
Director/Board Member 46 01/01/2015
Date Insider Type Main position Quantity % Market Cap.
2/13/26 A Buy

Director

582 0.0006%
12/30/25 A Buy

General Counsel

390 0.0004%
12/5/25 A Buy

Chief Financial Officer

2,000 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
-0.76%+1.36%+19.44%+17.21% 1.24B
-0.67%+1.37%+23.89%-7.04% 68.38B
+0.13%+2.49%+37.51%+190.54% 51.69B
-3.65%+34.50%+34.50%+34.50% 42.1B
-1.00%-1.28%-52.46%-54.56% 41.11B
-2.93%-4.34%+59.97%-27.21% 29.52B
-3.77%-11.22%+90.31%-52.32% 23.6B
-1.36%+1.24%+70.42%+80.67% 23.1B
+0.11%+2.67%+4.29%+181.86% 20.54B
-0.04%+1.85%+71.90%+121.88% 16.53B
Average -1.41%-0.98%+35.98%+48.55% 31.78B
Weighted average by Cap. -1.40%-0.85%+30.52%+44.60%

Financials

2026 *2027 *
Net sales 1.67B 172M 151M 139M 128M 242M 16.59B 246M 653M 8.12B 646M 632M 27.97B 1.86B 192M 168M 156M 143M 270M 18.51B 274M 729M 9.06B 721M 705M 31.21B
Net income 402M 41.5M 36.37M 33.62M 30.92M 58.34M 4B 59.28M 158M 1.96B 156M 152M 6.75B 490M 50.58M 44.33M 40.98M 37.69M 71.11M 4.88B 72.25M 192M 2.39B 190M 186M 8.22B
Net Debt -674M -69.57M -60.98M -56.37M -51.84M -97.82M -6.71B -99.38M -264M -3.28B -261M -256M -11.31B -698M -72.05M -63.15M -58.37M -53.69M -101M -6.95B -103M -274M -3.4B -271M -265M -11.71B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
21/07/26 SEK 119.20 +0.17% 3,409
20/07/26 SEK 119.00 -4.65% 276,178
17/07/26 SEK 124.80 +7.59% 598,880
16/07/26 SEK 116.00 -0.34% 376,158
15/07/26 SEK 116.40 -1.02% 97,595
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
119.00SEK
Average target price
165.00SEK
Spread / Average Target
+38.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock